Humana turns to game theory for new Medicare price structure


2011 Gain: $32.87 (60%) 2011 Closing price: $87.61 Last year, investors turned away from HMO stocks such as this, fearing the impact of a new health care overhaul rule involving medical-loss ratios. However, Humana showed it was able to manage the new regulation and in October delivered better-than-expected profits and a better-than-expected forecast for 2012. Stephen Weiss, partner at Short Hills Capital, “At eight times earnings, you’re owning a stock that’s still cheap and very, very defensiv

Humana executives say they are modeling a number of scenarios to try to figure out how they’ll price their Medicare drug plans for 2020 as the health insurance industry awaits new pharmacy benefit rebate regulations expected this spring from the Trump administration.

Source link

Leave a Comment

UPS eyes in-home health services with U.S. vaccine projectAdvertising watchdog rules fake autism 'cure' adverts must stop